References
- Van Eyken E, Van Camp G, Van Laer L. The complexity of age-related hearing impairment: contributing environmental and genetic factors. Audiol Neuro-Otol. 2007;12:345–358.
- Helzner EP, Cauley JA, Pratt SR, et al. Hearing sensitivity and bone mineral density in older adults: the Health, Aging and Body Composition Study. Osteoporos Int. 2005;16:1675–1682.
- Cornwell GG, III, Murdoch WL, Kyle RA, et al. Frequency and distribution of senile cardiovascular amyloid. A clinicopathologic correlation. Am J Med. 1983;75:618–623.
- Damy T, Jaccard A, Guellich A, et al. Identification of prognostic markers in transthyretin and AL cardiac amyloidosis. Amyloid. 2016;23:194–202.
- Nakagawa M, Sekijima Y, Yazaki M, et al. Carpal tunnel syndrome: a common initial symptom of systemic wild-type ATTR (ATTRwt) amyloidosis. Amyloid. 2016;23:58–63.
- Westermark P, Westermark GT, Suhr OB, et al. Transthyretin-derived amyloidosis: probably a common cause of lumbar spinal stenosis. Upsala J Med Sci. 2014;119:223–228.
- Sueyoshi T, Ueda M, Sei A, et al. Spinal multifocal amyloidosis derived from wild-type transthyretin. Amyloid. 2011;18:165–168.
- Dyck PJB, Grogan M, Klein C, et al. Polyneuropathy from wild transthyretin amyloidosis: an important new variety (P3.156) [abstract]. Neurology. 2016;86. Available from: http://www.neurology.org/content/86/16_Supplement/P3.156
- Lam L, Margeta M, Layzer R. Amyloid polyneuropathy caused by wild-type transthyretin. Muscle Nerve. 2015;52:146–149.
- Visser AC, Klein CJ. Wild-type TTR neuropathy with cardiomyopathy presenting with burning feet. Neurology. 2017;88:1101–1102.
- Gillmore JD, Maurer MS, Falk RH, et al. Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation. 2016;133:2404–2412.
- Galat A, Rosso J, Guellich A, et al. Usefulness of (99m)Tc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis. Amyloid. 2015;22:210–220.
- Phan NT, McKenzie JL, Huang L, et al. Diagnosis and management of hearing loss in elderly patients. Aust Fam Physician. 2016;45:366–369.
- Bahng J, Lee J. Hearing Thresholds for a geriatric population composed of korean males and females. J Audiol Otol. 2015;19:91–96.
- Klein CJ, Nakumura M, Jacobson DR, et al. Transthyretin amyloidosis (serine 44) with headache, hearing loss, and peripheral neuropathy. Neurology. 1998;51:1462–1464.
- Lossos A, Soffer D, Steiner-Birmanns B, et al. Extended phenotype in the transthyretin Tyr77 familial amyloid polyneuropathy. Eur Neurol. 2005;53:55–59.
- Sekijima Y, Hammarstrom P, Matsumura M, et al. Energetic characteristics of the new transthyretin variant A25T may explain its atypical central nervous system pathology. Lab Invest. 2003;83:409–417.
- Klockars T, Perheentupa T, Dahl HH. In silico analyses of mouse inner-ear transcripts. J Assoc Res Otolaryngol. 2003;4:24–40.